semaglutide clinical trials boosts walking ability in diabetes patients with peripheral artery disease, trial finds American Federation of Medical Research

Semaglutide offers a medically proven approach to achieving significant, sustainable weight loss

At the end of April, Novo Nordisk announced it would collaborate with three telehealth companies to offer Wegovy through its own mail-order pharmacy at a lower cash-pay price

TelX), which is rare in this space Four named pharmacy partners with no disciplinary history (Epiq Scripts, Southend, AbsoluteRx, Emerald Compounding) LegitScript certified with a dedicated HIPAA notice in the footer Best-in-class packaging: foam-insulated box, two gel ice packs, and a goody bag with ginger chews and mints for nausea Patient portal reinforces the recurring price after the first-month promo, which most providers do not bother to do Room for improvement Almost no third-party review presence (no Trustpilot, no BBB profile, only sparse Reddit threads) Public-facing ad creative leads with $179 first-month pricing without clarifying the $249 recurring cost Cancellation requires emailing support since the in-portal Cancel buttons route to dead links True Cost Analysis How clear and fair is their pricing

Unpacking the GLP-1 Hype: Chris Schott breaks down the trends shaping the market at #JPMHC24

Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and VirchowRobin perivascular spaces